Physiological Response to 5 Days Fasting
Physiological Response to Prolonged Fasting in Healthy Volunteers
1 other identifier
interventional
55
1 country
1
Brief Summary
To investigate energy metabolism, anthropometry, blood pressure, gut microbiome, serum metabolome, glucose variability and neural mechanisms of food choice and mood before and after 5 days of fasting as well as their persistence in healthy men and women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Nov 2020
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2020
CompletedFirst Posted
Study publicly available on registry
July 1, 2020
CompletedStudy Start
First participant enrolled
November 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedAugust 21, 2024
August 1, 2024
2.1 years
June 23, 2020
August 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Resting Energy Expenditure
Measured by indirect calorimetry (kcal/d)
6-th day of fasting compared to baseline
Secondary Outcomes (15)
Resting Energy Expenditure - Recovery
12 weeks after fasting compared to baseline
Resting Respiratory Exchange Ratio
6-th day of fasting and 28 days after fasting compared to baseline
Office systolic blood pressure
6-th day of fasting and 12 weeks after fasting compared to baseline
Office diastolic blood pressure
6-th day of fasting and 12 weeks after fasting compared to baseline
Fecal microbiome composition
6-th day of fasting and 12 weeks after fasting compared to baseline
- +10 more secondary outcomes
Study Arms (2)
Fasting
ACTIVE COMPARATORStarts immediately with 5 days of Buchinger fasting
Waiting list control
PLACEBO COMPARATORStarts with 5 days of Buchinger fasting after a waiting period of 12 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Men and women
- years
- Body mass index 20-30 kg/m2
You may not qualify if:
- Clinically relevant heart, lung, liver, and kidney diseases
- Any prescribed medication (except for oral contraceptives)
- Current or chronic infection
- Intake of antibiotics within 6 months before study entry
- Fasting week within 6 months before study entry
- Habitual use of dietary supplements
- Food intolerances
- Pregnancy, lactation
- Vegan diet
- Smokers
- In addition for fMRI: sensorineural hearing loss, tinnitus, metal implants, electric devices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité Universitätsmedizin Berlin
Berlin, 13125, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvia Bähring, PhD
Charite University, Berlin, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 23, 2020
First Posted
July 1, 2020
Study Start
November 2, 2020
Primary Completion
December 14, 2022
Study Completion
July 1, 2024
Last Updated
August 21, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 9 months and ending 36 months following article publication.
- Access Criteria
- Researchers who provide a methodologically sound proposal.
Individual participant data that underlie the results of reported articles (text, tables, figures, supplemental data) will be shared after deidentification.